Monthly Archives: February 2012
Patient Recruitment via Social Media: Lessons Learned
By Marylyn Donahue.
All-told the Mayo Clinic’s recent pilot study on clinical trial patient recruitment using social media and online networks not only helped researchers assemble large and demographically diverse patient groups more quickly, but also less expensively than they could through other means.
“This study is a prime example of patient-initiated research that could be used [...]
Witty Touts GSK Pipeline in 4th Quarter Review
brightcove.createExperiences();
Posted in Emerging Markets, Europe, Global, News, R&D, Strategy Tagged financial, GlaxoSmithKline, GSK, patent expiries, pipeline, R&D, Research Leave a comment
Shrinking Economy Hits California Biosector
By Amy Ritter, Pharmaeutical Technology.
A report released on Feb. 8, 2012 from the California Healthcare Institute, BayBio and PwC shows that the shrinking economy, changes in investment strategies, and pressures on the pharmaceutical market have put the brakes on one of the US’s most robust biotechnology centers. California had enjoyed steady growth in its biotech [...]
Posted in Biotech, Guest Blog Tagged BayBio, biopharmaceuticals, Biotech, California Healthcare Institute, economy Leave a comment
Medical Economics: New Highs for a Historic Brand
Medical Economics has been named "Media Brand of the Year" but MM&M magazie, one of sister publication Pharm Exec's main competitors.
Posted in Advertising, Biotech, E-Media, Marketing, Medical Education, Strategy, healthcare Tagged Advanstar, life sciences, Medical Economics, MM&M, primary care physicians Leave a comment

Talkback from Tufts: Defending R&D Costs